These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 30385181)

  • 1. Management of diffuse glioma.
    Esparragosa I; Díez-Valle R; Tejada S; Gállego Pérez-Larraya J
    Presse Med; 2018; 47(11-12 Pt 2):e199-e212. PubMed ID: 30385181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Input of molecular analysis in medical management of primary brain tumor patients.
    Idbaih A; Duran-Peña A; Bonnet C; Ducray F
    Rev Neurol (Paris); 2015; 171(6-7):457-65. PubMed ID: 26026669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioma therapy in adults.
    Norden AD; Wen PY
    Neurologist; 2006 Nov; 12(6):279-92. PubMed ID: 17122724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
    Chen R; Cohen AL; Colman H
    Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of pediatric gliomas: implications for the development of future therapies.
    Pytel P
    Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S51-60. PubMed ID: 18076319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Present trend in the primary treatment of aggressive malignant glioma: glioblastoma multiforme.
    Parvez T
    Technol Cancer Res Treat; 2008 Jun; 7(3):241-8. PubMed ID: 18473496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment burden and long-term health deficits of patients with low-grade gliomas or glioneuronal tumors diagnosed during the first year of life.
    Liu APY; Hastings C; Wu S; Bass JK; Heitzer AM; Ashford J; Vestal R; Hoehn ME; Ghazwani Y; Acharya S; Conklin HM; Boop F; Merchant TE; Gajjar A; Qaddoumi I
    Cancer; 2019 Apr; 125(7):1163-1175. PubMed ID: 30620400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of anaplastic glioma.
    Wick W; Wiestler B; Platten M
    Cancer Treat Res; 2015; 163():89-101. PubMed ID: 25468227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment Recommendations for Adult Patients with Diffuse Gliomas of Grades II and III According to the New WHO Classification in 2016.
    Sasaki H; Yoshida K
    Neurol Med Chir (Tokyo); 2017 Dec; 57(12):658-666. PubMed ID: 28845038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advancements in multimodality treatment of gliomas.
    Hadziahmetovic M; Shirai K; Chakravarti A
    Future Oncol; 2011 Oct; 7(10):1169-83. PubMed ID: 21992729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse low-grade glioma: a review on the new molecular classification, natural history and current management strategies.
    Delgado-López PD; Corrales-García EM; Martino J; Lastra-Aras E; Dueñas-Polo MT
    Clin Transl Oncol; 2017 Aug; 19(8):931-944. PubMed ID: 28255650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biology and treatment of malignant glioma.
    Prados MD; Levin V
    Semin Oncol; 2000 Jun; 27(3 Suppl 6):1-10. PubMed ID: 10866344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment modalities for malignant gliomas with reference to their pathophysiology].
    Kobayashi S; Takakura K
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):11-7. PubMed ID: 3942392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-grade gliomas: reality and hopes.
    Mirimanoff RO
    Chin J Cancer; 2014 Jan; 33(1):1-3. PubMed ID: 24384235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Factors for Survival Outcome of High-Grade Multicentric Glioma.
    Wang T; Niu X; Gao T; Zhao L; Li J; Gan Y; Liu Y; Mao Q
    World Neurosurg; 2018 Apr; 112():e269-e277. PubMed ID: 29337167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
    Juratli TA; Schackert G; Krex D
    Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of 1p/19q codeletion and histology on outcomes of anaplastic gliomas treated with radiation therapy and temozolomide.
    Speirs CK; Simpson JR; Robinson CG; DeWees TA; Tran DD; Linette G; Chicoine MR; Dacey RG; Rich KM; Dowling JL; Leuthardt EC; Zipfel GJ; Kim AH; Huang J
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):268-76. PubMed ID: 25636755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Head's up on the treatment of malignant glioma patients.
    Armstrong TS
    Oncol Nurs Forum; 2009 Sep; 36(5):E232-40. PubMed ID: 19726382
    [No Abstract]   [Full Text] [Related]  

  • 19. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontiers in targeting glioma stem cells.
    Frosina G
    Eur J Cancer; 2011 Mar; 47(4):496-507. PubMed ID: 21185169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.